Charles River Laboratories International, Inc. Profile Avatar - Palmy Investing

Charles River Laboratories International, Inc.

Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It …
Medical - Diagnostics & Research
US, Wilmington [HQ]

Cash Flow Statements

15 Sheets · Starting from 2023
In Million USD. Margins, Growth Rates In %
Metric 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Operating Activities
Operating Cash Flow (OCF)
225.00 169.00 205.00 207.00 207.00 251.00 286.00 298.00 316.00 441.00 480.00 546.00 760.00 619.00 683.00
Operating Cash (Net)
225.00 169.00 205.00 207.00 207.00 251.00 286.00 298.00 316.00 441.00 480.00 546.00 760.00 619.00 683.00
Accounts Receivable
21.00 -5.00 7.00 -16.00 -19.00 -28.00 -16.00 -52.00 -48.00 -21.00 -8.00 -85.00 -26.00 -150.00 -33.00
Accounts Payable
-11.00 - - 2.00 -3.00 -7.00 4.00 1.00 22.00 - - -12.00 29.00 - - 44.00 -2.00 -20.00
Working Capital
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Investing Activities
Used Cash (Net)
-208.00 5.00 -36.00 -54.00 -74.00 -297.00 -320.00 -686.00 -72.00 -955.00 -681.00 -601.00 -1,437.00 -607.00 -563.00
Capital Expenditure
-80.00 -42.00 -49.00 -47.00 -39.00 -56.00 -63.00 -55.00 -82.00 -140.00 -140.00 -166.00 -228.00 -324.00 -318.00
Purchases of Investments
-102.00 -27.00 -24.00 -18.00 -17.00 -26.00 -34.00 -40.00 -46.00 -25.00 -22.00 -26.00 -45.00 -158.00 -54.00
Sale/Maturity of Investment
52.00 72.00 31.00 25.00 11.00 21.00 27.00 53.00 9.00 35.00 - - 11.00 6.00 4.00 6.00
Property, Plant, Equipment (P&PE)
-80.00 -42.00 -49.00 -47.00 -39.00 -56.00 -63.00 -55.00 -82.00 -140.00 -140.00 -166.00 -228.00 -324.00 -318.00
Acquisitions (Net)
-83.00 2.00 - - -16.00 -29.00 -234.00 -247.00 -648.00 47.00 -824.00 -515.00 -418.00 -1,170.00 -120.00 -194.00
Other Investing Activities
4.00 - - 5.00 2.00 - - -1.00 -2.00 3.00 - - - - -3.00 -1.00 - - -9.00 -2.00
Financing Activities
Used Cash (Net)
-80.00 -167.00 -271.00 -111.00 -84.00 -61.00 -4.00 -390.00 -208.00 -558.00 -231.00 -47.00 -672.00 -42.00 -85.00
Debt Repayment
-54.00 -381.00 -252.00 -140.00 -523.00 -194.00 -417.00 -656.00 -372.00 -2,201.00 -3,124.00 -2,200.00 -6,242.00 -2,932.00 -851.00
Dividends Paid
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Common Stock
45 356 283 64 165 122 156 35 145 51 52 70 86 63 49
Other Financing Activities
19.00 570.00 264.00 93.00 604.00 377.00 539.00 1,059.00 270.00 2,772.00 3,374.00 2,271.00 6,956.00 2,903.00 790.00
Cash Balances
Begin of Period
243.00 182.00 179.00 68.00 109.00 155.00 160.00 117.00 119.00 166.00 197.00 240.00 233.00 246.00 241.00
End of Period
182.00 179.00 68.00 109.00 155.00 160.00 117.00 117.00 166.00 197.00 240.00 233.00 246.00 241.00 284.00
Change
-61.00 -3.00 -110.00 40.00 46.00 4.00 -42.00 - - 46.00 30.00 42.00 -6.00 13.00 -5.00 43.00
Non-Cash Balances
Depreciation and Amortization
93.00 93.00 85.00 81.00 96.00 96.00 94.00 126.00 131.00 161.00 198.00 234.00 265.00 303.00 314.00
Stock Based Compensation
23.00 - - - - 21.00 24.00 31.00 40.00 43.00 44.00 - - 57.00 56.00 71.00 73.00 72.00
Other
25.00 418.00 18.00 27.00 6.00 -9.00 -12.00 - - -18.00 - - -12.00 -83.00 6.00 -62.00 -29.00
Highlighted metrics
Free Cash Flow (FCF)
145.00 126.00 156.00 160.00 167.00 194.00 223.00 243.00 233.00 301.00 340.00 380.00 532.00 294.00 365.00
Cash Conversion Cycle (CCC)
93.00 96.00 87.00 93.00 96.00 97.00 97.00 88.00 96.00 91.00 82.00 89.00 66.00 76.00 98.00
Invested Capital
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Other Operating Inflows/Outflows
End of CRL's Analysis
CIK: 1100682 CUSIP: 159864107 ISIN: US1598641074 LEI: - UEI: -
Secondary Listings
CRL has no secondary listings inside our databases.